Author's Reply to Ma et al.: "Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis".
Brigida Anna MaioranoAndrea NecchiMassimo Di MaioPublished in: Targeted oncology (2024)
Keyphrases
- prostate cancer
- systematic review
- radical prostatectomy
- meta analyses
- squamous cell carcinoma
- small cell lung cancer
- dna damage
- genome wide
- dna repair
- oxidative stress
- case control
- bioinformatics analysis
- genome wide identification
- gene expression
- dna methylation
- randomized controlled trial
- breast cancer risk
- transcription factor